Zymeworks, Inc. (ZYME)
25.96
+0.48
(+1.90%)
USD |
NASDAQ |
Dec 15, 16:00
25.96
0.00 (0.00%)
After-Hours: 19:06
Zymeworks Research and Development Expense (TTM): 142.83M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Jazz Pharmaceuticals Plc | 809.33M |
| Johnson & Johnson | 15.77B |
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| CorMedix, Inc. | 12.46M |